Black Diamond Therapeutics Inc (BDTX) — Cash Flow Quality Index
Black Diamond Therapeutics Inc (BDTX) has a Cash Flow Quality Index of 0.94x as of March 2025. Operating cash flow of $53.41 Million is below net income of $56.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Black Diamond Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Black Diamond Therapeutics Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Black Diamond Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see BDTX cash flow metrics.
Annual Cash Flow Quality Index for Black Diamond Therapeutics Inc (2025–2025)
Year-by-year earnings quality comparison for Black Diamond Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.32x | $29.61 Million | $22.37 Million | — |